Pseudoprogression appears to be much rarer in all other tumour types (less than 3%), especially with the use of anti-PD1/PD-L1 agents, indicating that in the vast majority of patients progression seen on morphological imaging is authentic progression. Here, PDCD1 is linked to neoplasm.